Synergy CHC Cash on Hand 2023-2025 | SNYR
Synergy CHC cash on hand from 2023 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
|
Synergy CHC Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $1 |
| 2023 | $1 |
| 2022 | $3 |
|
Synergy CHC Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-06-30 | $2 |
| 2025-03-31 | $0 |
| 2024-12-31 | $1 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2022-12-31 | $3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.020B | $0.035B |
| Synergy CHC Corp. is a provider of consumer health care, beauty and lifestyle products. The company's current brand portfolio consists of marquee brands, FOCUSfactor, a clinically-tested brain health supplement and Flat Tummy, a lifestyle and wellness brand which provides a suite of nutritional products to help women achieve their weight management goals. Synergy CHC Corp. is based in Westbrook, Maine. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $152.423B | 27.99 |
| HCA Healthcare (HCA) | United States | $105.496B | 17.47 |
| CVS Health (CVS) | United States | $101.390B | 11.66 |
| Cencora (COR) | United States | $70.781B | 22.83 |
| Elevance Health (ELV) | United States | $70.061B | 10.27 |
| Natera (NTRA) | United States | $28.530B | 0.00 |
| DiDi Global (DIDIY) | China | $25.745B | 21.04 |
| Labcorp Holdings (LH) | United States | $22.235B | 16.95 |
| Medpace Holdings (MEDP) | United States | $16.979B | 42.15 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.630B | 0.00 |
| ICON (ICLR) | Ireland | $13.197B | 13.10 |
| Viatris (VTRS) | United States | $12.900B | 4.81 |
| Solventum (SOLV) | United States | $12.814B | 12.44 |
| CochLear (CHEOY) | Australia | $12.308B | 0.00 |
| Revvity (RVTY) | United States | $10.692B | 19.69 |
| HealthEquity (HQY) | United States | $8.601B | 34.42 |
| Charles River Laboratories (CRL) | United States | $8.539B | 16.44 |
| Avantor (AVTR) | United States | $7.841B | 11.98 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.099B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.850B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.116B | 36.46 |
| Bausch + Lomb (BLCO) | Canada | $5.819B | 38.21 |
| Sotera Health (SHC) | United States | $4.582B | 22.10 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $4.044B | 71.02 |
| Alignment Healthcare (ALHC) | United States | $3.298B | 0.00 |
| Concentras Parent (CON) | United States | $2.510B | 15.66 |
| Premier (PINC) | United States | $2.325B | 22.54 |
| Progyny (PGNY) | United States | $2.053B | 40.36 |
| Surgery Partners (SGRY) | United States | $2.036B | 26.24 |
| Ardent Health (ARDT) | United States | $2.011B | 7.76 |
| Establishment Labs Holdings (ESTA) | $1.989B | 0.00 | |
| Organon (OGN) | United States | $1.955B | 2.06 |
| Pediatrix Medical (MD) | United States | $1.942B | 11.60 |
| PACS (PACS) | United States | $1.876B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.342B | 0.00 |
| Omada Health (OMDA) | $1.205B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.053B | 16.83 |
| CareDx (CDNA) | United States | $0.863B | 14.10 |
| Embecta (EMBC) | United States | $0.832B | 4.87 |
| InnovAge Holding (INNV) | United States | $0.735B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.647B | 8.92 |
| Nutex Health (NUTX) | United States | $0.622B | 9.42 |
| Sonida Senior Living (SNDA) | United States | $0.600B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.547B | 0.00 |
| Pomdoctor - (POM) | China | $0.536B | 0.00 |
| Charming Medical (MCTA) | $0.497B | 0.00 | |
| CryoPort (CYRX) | United States | $0.443B | 0.00 |
| So-Young (SY) | China | $0.431B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.412B | 0.00 |
| Enhabit (EHAB) | United States | $0.404B | 18.16 |
| Auna S.A (AUNA) | Luxembourg | $0.386B | 5.80 |
| SBC Medicals (SBC) | United States | $0.353B | 7.73 |
| Oncology Institute (TOI) | United States | $0.314B | 0.00 |
| KindlyMD (NAKA) | United States | $0.308B | 0.00 |
| Agilon Health (AGL) | United States | $0.257B | 0.00 |
| LifeMD (LFMD) | United States | $0.240B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.231B | 0.00 |
| Beauty Health (SKIN) | United States | $0.166B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.142B | 0.00 |
| DocGo (DCGO) | United States | $0.108B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.101B | 0.00 |
| Biodesix (BDSX) | United States | $0.066B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.027B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.024B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |